Nextgen Biomed Ltd (NXGN)

Nov 10, 2023 - NXGN was delisted (reason: acquired by Thoma Bravo)

23.94

+0.03 (0.13%)

Inactive · Last trade price on Nov 8, 2023

NextGen Healthcare Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.02	0.05	5.24	11.96	5.67
Short-Term Investments	0.02	0.02	-	-	0.02
Cash & Short-Term Investments	0.04	0.07	5.24	11.96	5.69
Cash Growth	-46.15%	-98.76%	-56.19%	110.08%	199.63%
Other Receivables	0.1	0.07	-	0.15	0.16
Receivables	0.1	0.07	-	0.15	0.16
Prepaid Expenses	0.06	0.01	0.01	0.16	0.05
Restricted Cash	0.03	0.08	-	-	-
Total Current Assets	0.23	0.23	5.25	12.27	5.9
Property, Plant & Equipment	0.31	0.03	-	0.01	0.01
Other Intangible Assets	-	-	1.55	7.29	-
Other Long-Term Assets	0.03	-	-	-	0.5
Total Assets	0.58	0.26	14.89	23.63	8.32

Liabilities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Accounts Payable	0.18	0.15	0.17	0.14	0.07
Accrued Expenses	2.5	1.02	1.09	0.73	0.63
Current Portion of Leases	0.11	-	-	-	-
Other Current Liabilities	0.14	0.07	-	-	0.75
Total Current Liabilities	2.92	1.24	1.26	0.87	1.45
Long-Term Leases	0.12	-	-	-	-
Other Long-Term Liabilities	-	-	1.38	2.14	-
Total Liabilities	3.04	1.24	2.64	3.01	1.45

Shareholders' Equity

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Additional Paid-In Capital	67.08	64.4	63.43	57.96	38.2
Retained Earnings	-70.94	-66.05	-51.86	-43.29	-40.74
Treasury Stock	-0.01	-0.01	-0.01	-0.01	-0.01
Comprehensive Income & Other	1.53	0.8	0.8	6.07	9.52
Total Common Equity	-2.34	-0.86	12.36	20.72	6.97
Minority Interest	-0.12	-0.12	-0.11	-0.1	-0.1
Shareholders' Equity	-2.47	-0.98	12.25	20.62	6.87
Total Liabilities & Equity	0.58	0.26	14.89	23.63	8.32

Additional Metrics

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Total Debt	0.22	-	-	-	-
Net Cash (Debt)	-0.19	0.07	5.24	11.96	5.69
Net Cash Growth	-	-98.76%	-56.19%	110.08%	199.63%
Net Cash Per Share	-0.02	0.01	0.73	1.80	1.05
Filing Date Shares Outstanding	10.9	7.29	7.22	7.22	6.34
Total Common Shares Outstanding	10.9	7.29	7.22	7.22	5.53
Working Capital	-2.7	-1.01	3.99	11.4	4.45
Book Value Per Share	-0.21	-0.12	1.71	2.87	1.26
Tangible Book Value	-2.34	-0.86	10.81	13.43	6.97
Tangible Book Value Per Share	-0.21	-0.12	1.50	1.86	1.26

SEC Filings: 10-K · 10-Q